patent/RU-2098087-C1

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c5813b7cb1c8f57ecd84b62bb4884027
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4425
filingDate	1994-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate	1997-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c406518fe07561069435d382ed89bde3
publicationDate	1997-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	RU-2098087-C1
titleOfInvention	Method of leukosis treatment
abstract	FIELD: medicine, oncology. SUBSTANCE: method involves the use of N1-methyl-6-pyridone-3-carboxamide (6-pyridone) as a medicinal preparation. Preparation is dosed by 0.35-0.50 mg/kg, 1 h before meal, 3 times per a day for 1.5-2.5 months. Drug is synthesized by chemical method. Preparation recoveries tryptophan metabolism by kinurenine type, normalizes immune system and shows stable remission. EFFECT: enhanced effectiveness of treatment.
priorityDate	1994-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419586722 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484563 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8871 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425154543 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69698 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396416

Total number of triples: 21.